CD8A and tuberculosis: In the study, the authors asked whether QFT-Plus use might be more advantageous than QFT-GIT in an immunosuppressed population because QFT-Plus has two TB antigen tubes that stimulate IFN-γ production by CD8+ T cells and CD4+ T cells.